Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Adrenal Cancer

sorafenib has been researched along with Adrenal Cancer in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Abe, H; Endo, S; Ishii, S; Ishikawa, N; Kamimura, K; Ko, M; Koseki, Y; Ogawa, K; Sakai, N; Sakamaki, A; Shibata, O; Terai, S; Yokoyama, J1
Alexandrescu, ST; Croitoru, AE; Droc, G; Grasu, MC; Grigorie, RT; Popescu, I; Tomescu, DR1
Jiang, W; Zeng, ZC1
Haraldsdottir, S; Ing, SW; Kendra, K; Li, Q; Olencki, TE; Villalona-Calero, MA1
Anouar, Y; Baudin, E; Denorme, M; Dubessy, C; Gonzalez, BJ; Roux, C; Yon, L1
Bitzer, M; Claussen, CD; Hartmann, JT; Horger, M; Maksimovic, O; Pintoffl, J; Schraml, C1
Fujimoto, T; Itatani, H; Kamoto, A; Kanemitu, T; Kobayashi, Y; Mori, N; Satoh, M; Sekii, K; Yoshioka, T1
Artéaga, C; Brardjanian, S; Coton, T; Fabries, P; Guisset, M; Pauleau, G1

Reviews

1 review(s) available for sorafenib and Adrenal Cancer

ArticleYear
Effects of Atezolizumab and Bevacizumab on Adrenal Gland Metastasis of Hepatocellular Carcinoma: A Case Report and Review of Literature.
    Internal medicine (Tokyo, Japan), 2022, Nov-01, Volume: 61, Issue:21

    Topics: Adrenal Gland Neoplasms; Adrenal Glands; Bevacizumab; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Sorafenib

2022

Other Studies

7 other study(ies) available for sorafenib and Adrenal Cancer

ArticleYear
Aggressive surgical approach in patients with adrenal-only metastases from hepatocellular carcinoma enables higher survival rates than standard systemic therapy.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2021, Volume: 20, Issue:1

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Progression-Free Survival; Retrospective Studies; Romania; Sorafenib; Survival Rate; Treatment Outcome

2021
Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?.
    Oncology, 2013, Volume: 84 Suppl 1

    Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Disease-Free Survival; Ethiodized Oil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Niacinamide; Phenylurea Compounds; Practice Guidelines as Topic; Retrospective Studies; Sorafenib; Survival Rate

2013
Case of sorafenib-induced thyroid storm.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jun-01, Volume: 31, Issue:16

    Topics: Adrenal Gland Neoplasms; Aged; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Atrial Fibrillation; Biomarkers; Bone Neoplasms; Carcinoma, Renal Cell; Drug Administration Schedule; Fatal Outcome; Heart Arrest; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Muscle Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Respiratory Aspiration; Sorafenib; Thyroid Crisis; Thyroid Hormones

2013
Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
    Cancer letters, 2014, Oct-01, Volume: 352, Issue:2

    Topics: Administration, Oral; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Heterografts; Indoles; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Niacinamide; PC12 Cells; Phenylurea Compounds; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Rats; Sorafenib; Sunitinib; Time Factors; Tumor Burden

2014
Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment.
    AJR. American journal of roentgenology, 2010, Volume: 194, Issue:1

    Topics: Adrenal Gland Neoplasms; Aged; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pheochromocytoma; Protein Kinase Inhibitors; Pyridines; Sensitivity and Specificity; Sorafenib; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography

2010
Painless acute pancreatitis associated with sorafenib treatment: a case report.
    Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:2

    Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Immunologic Factors; Interferon-alpha; Kidney Neoplasms; Male; Niacinamide; Pancreatitis; Phenylurea Compounds; Pyridines; Sorafenib

2011
[Metastatic adrenal necrosis under sorafenib treatment for hepatocellular carcinoma].
    Presse medicale (Paris, France : 1983), 2013, Volume: 42, Issue:2

    Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Antineoplastic Agents; Carcinoma, Hepatocellular; Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Necrosis; Niacinamide; Phenylurea Compounds; Sorafenib

2013